MHRA Enforcement on Invalid Certification: What Importers and Distributors Should Be Checking

Two recent MHRA announcements point in the same direction. On 10 August 2026 the MHRA issued safety alert DSI/2026/007, telling healthcare organisations and distributors to stop using and supplying six devices found on the UK market without valid UKCA or CE conformity markings or certification. On 24 September 2026 it welcomed the sentencing in a fraud case concerning devices supplied with invalid CE marking.

The short version is this. A conformity mark on a label is a claim, and the MHRA expects the supply chain to test that claim. If you import or distribute devices into the UK or the EU, checking the marking and the certificate behind it is part of your role, and these cases show what happens when the checks are missing.

The alert: DSI/2026/007

The alert covers six products from six manufacturers, including a bone marrow biopsy needle, sterile gauze swabs, an antiseptic adhesive bandage, alcohol swabs, a scalpel and a blood collection, infusion and scalp vein set. The full list of products and manufacturers is in the alert.

The MHRA states that it has not identified any specific defect, performance issue or safety signal with the products. The concern is regulatory. In the alert’s words, “without legitimate UKCA or CE device certification required for supply on the UK market, assurance regarding conformity assessment, quality management systems, safety, sterility and performance cannot be fully guaranteed.”

The actions are immediate. Healthcare professionals are asked to stop using the devices, quarantine remaining stock and source compliant alternatives. Distributors are asked to cease further supply, notify the MHRA at devices.compliance@mhra.gov.uk if they think they have received, supplied or distributed any affected devices, and inform their customers. The MHRA published an accompanying news release on the same day.

The prosecution: Medicina Limited

The second announcement concerns a case the MHRA’s Devices Compliance Unit first identified in 2013. On 1 July 2026 Medicina Limited and one of its directors were found guilty of fraud offences relating to P900 enteral feeding pumps, gastrostomy button devices and blunt fill needles. The MHRA reports that the devices were supplied with invalid CE marking, falsely assuring healthcare providers that they met the necessary safety standards. The enteral feeding pumps were used in neonatal intensive care units.

At Manchester Crown Court on 23 September 2026 the director received a three-year prison sentence suspended for three years, 175 hours of community service and 10 days of rehabilitation activity, and was disqualified from acting as a company director for eight years. The MHRA states that a date is yet to be fixed for the sentencing of Medicina Limited.

The case took more than a decade to reach this point. Over that period the MHRA issued safety alerts, oversaw recalls and instructed the company to stop supplying the devices. The practical lesson for the supply chain is that invalid marking can sit on products in routine hospital use for a long time before enforcement concludes.

Where the duty to check sits

Great Britain

In Great Britain, devices must carry a valid UKCA mark or, under the current arrangements, a valid CE mark. MHRA guidance allows CE marked devices to be placed on the GB market until 30 June 2028 for devices compliant with the MDD or AIMDD, and until 30 June 2030 for devices compliant with the IVDD, EU MDR or EU IVDR.

For non-UK manufacturers, the UK Responsible Person carries a specific verification task. MHRA guidance states that the UK Responsible Person must “ensure that the declaration of conformity and technical documentation have been drawn up and, where applicable, that an appropriate conformity assessment procedure has been carried out”, and must keep available a copy of the declaration of conformity and, where applicable, the relevant certificate. The same guidance expects importers and distributors to check labelling for UKCA or CE marking. The alert shows the MHRA acting directly on distributors when those checks fail. Our guide to the UK Responsible Person and UKCA marking covers the role in more detail.

European Union

The EU MDR sets the duties out article by article. Under Article 13, importers must verify, before placing a device on the market, that it is CE marked and that the EU declaration of conformity has been drawn up, that the manufacturer is identified and has designated an authorised representative, that the device is labelled and accompanied by the required instructions for use, and that a UDI has been assigned where applicable. Under Article 14, distributors must verify that the device is CE marked, that the declaration of conformity has been drawn up, that the required information accompanies it, that the importer has met its labelling duties and that a UDI has been assigned. Distributors may use a representative sampling method for some of these checks.

Both articles also require action where something looks wrong. An importer or distributor that considers, or has reason to believe, that a device is not in conformity must not place it on the market or make it available until it has been brought into conformity, and must inform the manufacturer and, where relevant, other economic operators. If the device presents a serious risk or is a falsified device, the competent authority must be informed. We cover these duties in more depth in our posts on importer obligations and the difference between an importer and a distributor.

What to do next

If you import or distribute devices, these are the checks worth building into routine supplier qualification and goods-in.

  1. Read the declaration of conformity. Confirm it names the manufacturer, the device and the correct regulation (UK MDR 2002, EU MDR or EU IVDR), is signed and dated, and references the notified body or UK Approved Body certificate where one is required.
  2. Check the certificate at source. For CE marked devices above Class I, confirm on NANDO that the notified body is designated for that regulation and device scope, then check the certificate itself in the EUDAMED certificates module or directly with the notified body. For UKCA marked devices, confirm the body appears on the MHRA’s list of UK Approved Bodies and verify the certificate with that body.
  3. Match the certificate to the product. Check that the certificate is current, has not been suspended or withdrawn, and covers the device type, model and manufacturer on the label. A valid certificate for a different product range gives no assurance.
  4. Check registration. For Great Britain, confirm the device is registered with the MHRA through the public registration database. For the EU, check the actor and device records in EUDAMED.
  5. Qualify the supplier. Record these checks in a supplier file, repeat them at a defined interval, and put the obligation to notify you of certificate changes into your quality agreement. Our post on whether importers need a QMS sets out how this fits into a documented system.
  6. Know your escalation route. If a check fails, quarantine the stock, contact the manufacturer and, where the facts warrant it, the competent authority. For GB, the alert gives devices.compliance@mhra.gov.uk as the contact.

Where you act as UK Responsible Person or EU authorised representative for a manufacturer, the same discipline applies to the documentation you hold on file. An expired or out-of-scope certificate in your records is a finding waiting to happen.

Specculo supports manufacturers, importers and distributors with UK Responsible Person services, supplier verification and quality system set-up. If you would like a review of how your team checks certification before stock moves, get in touch.

Sources